Skip to main navigation Skip to search Skip to main content

Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection

  • The Catholic University of Korea

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Tenofovir disoproxil fumarate (TDF) is widely used as an effective first-line therapy for chronic hepatitis B (CHB) infection. While TDF demonstrates successful viral suppression, it has been linked to the development of renal proximal tubular (PT) dysfunction, leading to Fanconi syndrome. However, Fanconi syndrome has been rarely reported in CHB-monoinfected patients, and there were no reports of TDF-associated nephrotic syndrome. Here, we report a case of combined Fanconi and nephrotic syndrome in CHB patients after TDF exposure.

Original languageEnglish
Pages (from-to)1318-1320
Number of pages3
JournalHepatology
Volume62
Issue number4
DOIs
StatePublished - 1 Oct 2015

Bibliographical note

Publisher Copyright:
© 2015 by the American Association for the Study of Liver Diseases.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection'. Together they form a unique fingerprint.

Cite this